Fluorescein
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00693 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Prinzmetal angina | KG + DL |
| 2 | antithrombin deficiency type 2 | KG + DL |
| 3 | rheumatoid arthritis | KG + DL |
| 4 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 5 | hemoglobinopathy | KG + DL |
| 6 | heparin cofactor 2 deficiency | KG + DL |
| 7 | thrombophilia | KG + DL |
| 8 | hyperthyroidism | KG + DL |
| 9 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 10 | beta-thalassemia with other manifestations | KG + DL |
| 11 | thrombotic disease | KG + DL |
| 12 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 13 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 14 | amenorrhea (disease) | KG + DL |
| 15 | pyropoikilocytosis, hereditary | KG + DL |
| 16 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 17 | brachydactyly-syndactyly syndrome | KG + DL |
| 18 | pyruvate kinase deficiency of red cells | KG + DL |
| 19 | homozygous familial hypercholesterolemia | KG + DL |
| 20 | non-inflammatory vasculopathy | KG + DL |
| 21 | peripheral vascular disease | KG + DL |
| 22 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 23 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 24 | hypoalphalipoproteinemia | KG + DL |
| 25 | angiodysplasia | KG + DL |
| 26 | venous thromboembolism | KG + DL |
| 27 | fibrocartilaginous embolism | KG + DL |
| 28 | vascular ectasia | KG + DL |
| 29 | conjunctivitis | KG + DL |
| 30 | diabetic nephropathy | KG + DL |
| 31 | peripheral arterial disease | KG + DL |
| 32 | congenital renal artery stenosis | KG + DL |
| 33 | HIV infectious disease | KG + DL |
| 34 | intermittent vascular claudication | KG + DL |
| 35 | ischemic disease | KG + DL |
| 36 | coronary thrombosis | KG + DL |
| 37 | sclerosing cholangitis | KG + DL |
| 38 | intracranial arteriosclerosis | KG + DL |
| 39 | breast fibrocystic disease | KG + DL |
| 40 | vein disease | KG + DL |
| 41 | multiple endocrine neoplasia | KG + DL |
| 42 | hyperthyroxinemia | KG + DL |
| 43 | arterial calcification of infancy | KG + DL |
| 44 | myocardial infarction | KG + DL |
| 45 | conjunctivitis (disease) | KG + DL |
| 46 | benign mammary dysplasia | KG + DL |
| 47 | bone Paget disease | KG + DL |
| 48 | Monckeberg arteriosclerosis | KG + DL |
| 49 | blindness (disorder) | KG + DL |
| 50 | hereditary arterial and articular multiple calcification syndrome | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.